FUNCTIONAL INTERACTION BETWEEN HUMAN HISTOCOMPATIBILITY LEUKOCYTE ANTIGEN (HLA) CLASS-II AND MOUSE CD4 MOLECULE IN ANTIGEN RECOGNITION BY T-CELLS IN HLA-DR AND DQ TRANSGENIC MICE

被引:33
作者
YAMAMOTO, K
FUKUI, Y
ESAKI, Y
INAMITSU, T
SUDO, T
YAMANE, K
KAMIKAWAJI, N
KIMURA, A
SASAZUKI, T
机构
[1] KYUSHU UNIV,MED INST BIOREGULAT,DEPT GENET,HIGASHI KU,FUKUOKA 812,JAPAN
[2] HAMANOUMACHI HOSP,DEPT PEDIAT,CHUO KU,FUKUOKA 810,JAPAN
关键词
D O I
10.1084/jem.180.1.165
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies in vitro have suggested that a species barrier exists in functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecules. However, whether mouse CD4(+) T cells restricted by HLA class II molecules are generated in HLA class II transgenic mice and respond to peptide antigens across this barrier has remained unclear. In an analysis of T cell responses to synthetic peptides in mice transgenic for HLA-DR51 and -DQ6, we found that DR51 and DQ6 transgenic mice acquired significant T cell response to influenza hemagglutinin-derived peptide 307-319 (HA 307) and Streptococcus pyogenes M12 protein-derived peptide 347-397 (M6C2), respectively. Inhibition studies with several monoclonal antibodies showed that transgenic HLA class II molecules presented these peptides to mouse CD4(+) T cells. Furthermore, T cell lines specific for HA 307 or M6C2 obtained from the transgenic mice could respond to the peptide in the context of relevant HLA class II molecules expressed on mouse L cell transfectants that lack the expression of mouse MHC class II. These findings indicate that interaction between HLA class II and mouse CD4 molecules is sufficient for provoking peptide-specific HLA class II-restricted T cell responses in HLA class II transgenic mice.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 30 条
[1]   SPECIES SPECIFICITY AND AUGMENTATION OF RESPONSES TO CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES IN HUMAN CD4 TRANSGENIC MICE [J].
BARZAGAGILBERT, E ;
GRASS, D ;
LAWRANCE, SK ;
PETERSON, PA ;
LACY, E ;
ENGELHARD, VH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) :1707-1715
[2]   IDENTIFICATION OF A CD4 BINDING-SITE ON THE BETA-2-DOMAIN OF HLA-DR MOLECULES [J].
CAMMAROTA, G ;
SCHEIRLE, A ;
TAKACS, B ;
DORAN, DM ;
KNORR, R ;
BANNWARTH, W ;
GUARDIOLA, J ;
SINIGAGLIA, F .
NATURE, 1992, 356 (6372) :799-801
[3]   THE CELL-SURFACE OF MOUSE DENDRITIC CELLS - FACS ANALYSES OF DENDRITIC CELLS FROM DIFFERENT TISSUES INCLUDING THYMUS [J].
CROWLEY, M ;
INABA, K ;
WITMERPACK, M ;
STEINMAN, RM .
CELLULAR IMMUNOLOGY, 1989, 118 (01) :108-125
[4]   CHARACTERIZATION OF THE MURINE ANTIGENIC DETERMINANT, DESIGNATED L3T4A, RECOGNIZED BY MONOCLONAL-ANTIBODY GK1.5 - EXPRESSION OF L3T4A BY FUNCTIONAL T-CELL CLONES APPEARS TO CORRELATE PRIMARILY WITH CLASS II MHC ANTIGEN-REACTIVITY [J].
DIALYNAS, DP ;
WILDE, DB ;
MARRACK, P ;
PIERRES, A ;
WALL, KA ;
HAVRAN, W ;
OTTEN, G ;
LOKEN, MR ;
PIERRES, M ;
KAPPLER, J ;
FITCH, FW .
IMMUNOLOGICAL REVIEWS, 1983, 74 :29-56
[5]   RESTRICTED EXPRESSION OF TRANSGENIC HLA-DRA GENE IN THYMIC EPITHELIAL-CELLS AND ITS ROLE IN ACQUISITION OF T-CELL TOLERANCE TO SELF-SUPERANTIGENS AND PROCESSED DR-ALPHA-DERIVED PEPTIDE [J].
FUKUI, Y ;
YAMAMOTO, K ;
YOKOYAMA, N ;
IWANAGA, T ;
KURASHIMA, C ;
ESAKI, Y ;
KIMURA, A ;
AKASHI, T ;
HIROKAWA, K ;
SASAZUKI, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) :1678-1686
[6]  
FUKUI Y, 1993, IMMUNOGENETICS, V37, P204, DOI 10.1007/BF00191886
[7]   FUNCTIONAL INTERACTION BETWEEN HUMAN T-CELL PROTEIN CD4 AND THE MAJOR HISTOCOMPATIBILITY COMPLEX HLA-DR ANTIGEN [J].
GAY, D ;
MADDON, P ;
SEKALY, R ;
TALLE, MA ;
GODFREY, M ;
LONG, E ;
GOLDSTEIN, G ;
CHESS, L ;
AXEL, R ;
KAPPLER, J ;
MARRACK, P .
NATURE, 1987, 328 (6131) :626-629
[8]   THE ROLE OF CD4 IN T-CELL ACTIVATION - ACCESSORY MOLECULE OR CO-RECEPTOR [J].
JANEWAY, CA .
IMMUNOLOGY TODAY, 1989, 10 (07) :234-238
[9]  
JANEWAY CA, 1984, J IMMUNOL, V132, P662
[10]  
KAMIKAWAJI N, 1991, J IMMUNOL, V146, P2560